Introduction: The burden of prostatic cancer is rising in Sudan. Usually, they present late in their disease with urinary tract obstruction, hematuria, bony pain, or cachexia because there is no screening program. Here we present a patient with prostatic cancer who presented with left axillary mass as his main concern. Case Description: 82-year-old Sudanese male presented with a left axillary and left supraclavicular lymphadenopathy of a few months’ duration. He underwent a decisional biopsy which showed metastatic adenocarcinoma. Upper and lower GI endoscopy were performed but the latter was complicated by a sigmoid perforation with peritonitis. During laparatomy, multiple enlarged pelvic lymphnodes were encountered and a biopsy result suggested a metastatic prostatic neoplasm. Later, prostatic biopsy confirmed the diagnosis. The patient was treated with bilateral orchidectomy. Clinical discussion: Lymphatic metastasis to axillary lymph nodes is a very rare manifestation of prostate cancer and only a few cases have been reported in the literature. It can cause diagnostic difficulty since prostate cancer typically metastasis to the pelvic lymph node and very rarely involves he supradiaphragmatic lymph node. Conclusion: Metastatic prostatic carcinoma should be considered among the causes of supra-diaphragmatic lymph adenopathy. Careful physical and imaging examinations combined with PSA and pathological analysis are essential in the diagnosis of advanced prostate cancer with unusual presentation.
References
[1]
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
[2]
Gann, P.H. (2002) Risk Factors for Prostate Cancer. Reviews in Urology, 4, S3-S10.
[3]
Bubendorf, L., Schöpfer, A., Wagner, U., et al. (2000) Metastatic Patterns of Prostate Cancer: An Autopsy Study of 1,589 Patients. Human Pathology, 31, 578-583. https://doi.org/10.1053/hp.2000.6698
[4]
Zdilla, M.J., Aldawood, A.M., Plata, A., Vos, J.A. and Lambert, H.W. (2019) Troisier Sign and Virchow Node: The Anatomy and Pathology of Pulmonary Adenocarcinoma Metastasis to a Supraclavicular Lymph Node. Autopsy and Case Reports, 9, e2018053. https://doi.org/10.4322/acr.2018.053
[5]
Carson, C., Murphy, B. and Kerr, O. (2019) Metastatic Malignant Melanoma: Axillary Lymphadenopathy and the Ugly Duckling Sign. Annals of Breast Surgery, 3, 1-3. https://doi.org/10.21037/abs.2019.01.03
[6]
Mohseni, S., Shojaiefard, A., Khorgami, Z., Alinejad, S. and Ghorbani, A. (2014) Peripheral Lymphadenopathy: Approach and Diagnostic Tools. Iranian Journal of Medical Sciences, 39, 158-170.
[7]
Wong, T.Y.E. and Nishihara, K. (2017) Virchow’s Node together with an Irish Node. Clinical Case Reports, 5, 1046-1047. https://doi.org/10.1002/ccr3.967
[8]
Agha, R.A., Franchi, T., Sohrabi, C., et al. (2020) The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines. International Journal of Surgery, 84, 226-230. https://doi.org/10.1016/j.ijsu.2020.10.034
[9]
Elamin, A., Ibrahim, M.E., Abuidris, D., Mohamed, K.E.H. and Mohammed, S.I. (2015) Part I: Cancer in Sudan—Burden, Distribution, and Trends Breast, Gynecological, and Prostate Cancers. Cancer Medicine, 4, 447-456. https://doi.org/10.1002/cam4.378
[10]
Khalid, K., Brair, A., Elhaj, A. and Ali, K. (2011) Prostate-Specific Antigen Level and Risk of Bone Metastasis in Sudanese Patients with Prostate Cancer. Saudi Journal of Kidney Diseases and Transplantation, 22, 1041-1043.
[11]
Hutt, M. (1987) Cancer Occurrence in Developing Countries. Journal of Clinical Pathology, 40, Article No. 474. https://doi.org/10.1136/jcp.40.4.474-a
[12]
Rawla, P. (2019) Epidemiology of Prostate Cancer. World Journal of Oncology, 10, 63-89. https://doi.org/10.14740/wjon1191
[13]
Ferlay, J., Soerjomataram, I., Dikshit, R., et al. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. https://doi.org/10.1002/ijc.29210
[14]
Collins, G.R., Lopez, Y. and Abreo, F. (2012) Prostatic Adenocarcinoma Metastatic to Axillary Lymph Node Diagnosed by Fine-Needle Aspiration Biopsy. Diagnostic Cytopathology, 40, 751-753. https://doi.org/10.1002/dc.21679
[15]
Vinjamoori, A.H., Jagannathan, J.P., Shinagare, A.B., et al. (2012) A Typical Metastases from Prostate Cancer: 10-Year Experience at a Single Institution. American Journal of Roentgenology, 199, 367-372. https://doi.org/10.2214/AJR.11.7533
[16]
Mremi, A., Mbwambo, O.J., Bright, F., Mbwambo, J.S., Mteta, K.A. and Ngowi, B.N. (2021) Left Axillary Lymphadenopathy as Initial Presentation of Metastatic Prostate Cancer: A Rare Case Report. International Journal of Surgery Case Reports, 82, Article ID: 105889. https://doi.org/10.1016/j.ijscr.2021.105889
[17]
Cho, K.R. and Epstein, J.I. (1987) Metastatic Prostatic Carcinoma to Supradiaphragmatic Lymph Nodes. A Clinicopathologic and Immunohistochemical Study. The American Journal of Surgical Pathology, 11, 457-463. https://doi.org/10.1097/00000478-198706000-00006
[18]
Pinaquy, J.B., Allard, J.B., Cornelis, F., Pasticier, G. and De Clermont, H. (2015) Unusual Lymph Node Metastases of Prostate Cancer Detected by 18F-Fluorocholine PET/CT. Clinical Nuclear Medicine, 40, e255-e257. https://doi.org/10.1097/RLU.0000000000000708
[19]
Tsujino, K., Sasada, S., Kawahara, K., et al. (2007) A Case of Prostatic Adenocarcinoma Clinically Presenting as Supraclavicular and Mediastinal Lymphadenopathy. The Journal of the Japanese Respiratory Society, 45, 648-653. (In Japanese)
[20]
Mupamombe, C.T., LoGiurato, B., Kampel, L. and Cohen, J.M. (2018) Unilateral Upper Extremity Lymphedema in Metastatic Prostate Cancer. Clinical Case Reports, 6, 1014-1019. https://doi.org/10.1002/ccr3.1367
[21]
Datta, K., Muders, M., Zhang, H. and Tindall, D.J. (2010) Mechanism of Lymph Node Metastasis in Prostate Cancer. Future Oncology, 6, 823-836. https://doi.org/10.2217/fon.10.33
[22]
Mohler, J.L., Antonarakis, E.S., Armstrong, A.J., et al. (2019) Prostate Cancer, Version 2 NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17, 479-505. https://doi.org/10.6004/jnccn.2019.0023
[23]
The American Cancer Society Medical and Editorial Content Team (2019) Prostate Cancer Stages and Other Ways to Assess Risk. https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/staging.html.